AMG National Trust Bank’s Xeris Biopharma Holdings XERS Stock Holding History

AMG National Trust Bank’s Portfolio XERS Stock Details XERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$238K	Buy	+30,000	New	+$192K	﹤0.01%	414

Other funds holding XERS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return

LCM

Legato Capital Management San Francisco, California $1.21B AUM 82.36% 1-Year Est. Return

AMG National Trust Bank's XERS Position: Q2 2026 in Review

AMG National Trust Bank opened a new position in Xeris Biopharma Holdings (XERS) in Q2 2026: 30,000 shares worth $238K. The stake represents ﹤0.01% of the portfolio and ranks #414 among its holdings.

78 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

AMG National Trust Bank held 30,000 shares of Xeris Biopharma Holdings worth $238K as of Q2 2026.
Xeris Biopharma Holdings was a new AMG National Trust Bank position in Q2 2026.
Xeris Biopharma Holdings made up ﹤0.01% of AMG National Trust Bank's portfolio in Q2 2026, its #414 holding.
78 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on AMG National Trust Bank's 13F filing for Q2 2026, filed 7 Aug 2026.